Provided by Tiger Fintech (Singapore) Pte. Ltd.

Personalis

4.00
-0.2600-6.10%
Volume:1.32M
Turnover:5.43M
Market Cap:353.05M
PE:-2.92
High:4.27
Open:4.27
Low:3.98
Close:4.26
Loading ...

Personalis Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
13 hours ago

Personalis Q1 EPS $(0.26), Inline, Sales $20.60M Beat $17.42M Estimate

Benzinga
·
14 hours ago

BRIEF-Personalis Q1 Net Income USD -15.75 Million Vs. IBES Estimate USD -20.4 Million

Reuters
·
14 hours ago

Personalis Q1 Basic EPS USD -0.18

THOMSON REUTERS
·
14 hours ago

Personalis Inc - Expects Full Year 2025 Revenue of $80-$90 Million

THOMSON REUTERS
·
14 hours ago

Personalis Inc expected to post a loss of 25 cents a share - Earnings Preview

Reuters
·
03 May

Personalis management to meet with Lake Street

TIPRANKS
·
01 May

Personalis updates on NeXT colorectal cancer detection study

TIPRANKS
·
29 Apr

Personalis to Announce First Quarter 2025 Financial Results

Business Wire
·
23 Apr

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Test for Residual Cancer and Recurrence Detection

Business Wire
·
22 Apr

Personalis to Participate at the 24th Annual Needham Virtual Healthcare Conference

Business Wire
·
27 Mar

BTIG Reaffirms Their Buy Rating on Personalis (PSNL)

TIPRANKS
·
18 Mar

Craig-Hallum bullish on Personalis, initiates with a Buy

TIPRANKS
·
17 Mar

Craig Hallum Initiates Coverage on Personalis With Buy Rating, $8 Price Target

MT Newswires Live
·
17 Mar

New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

Business Wire
·
03 Mar

Personalis Full Year 2024 Earnings: Beats Expectations

Simply Wall St.
·
01 Mar

Personalis’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
01 Mar

Analysts Offer Insights on Healthcare Companies: Heron Therapeutics (HRTX), Milestone Pharmaceuticals (MIST) and Personalis (PSNL)

TIPRANKS
·
28 Feb

Personalis Is Maintained at Buy by Needham

Dow Jones
·
28 Feb

Personalis Price Target Maintained With a $8.00/Share by HC Wainwright & Co.

Dow Jones
·
28 Feb